If there was any good news really imminent, this would work its way up gradually over a period of days, not jump suddenly and then nosedive on massive volume. Last Friday: Surges to 3,30, closes at 3.18 on 10.6 million shares. Closes Monday at 2.95.
Today: Surges to 3.66 on 8.6m shares, closes at 3.26. Monday, in the absence of news, it should be back close to 3. I think you guys are being played.
Okay, I had correctly surmised that you had gone long. Which I would certainly never have done. Might have been nice to have some stops in on half your position at, say 3.40. You seem to find it incredible that I own 40 stocks. (42 actually, not counting the residual rights to Trius and DYAX). But, seriously, why would you not own FB, APPL (or, in my case, SWKS, which amounts to the same thing), an airline, a car company, a bank, a homebuilder, etc. ? You have to break this addiction to drugs (or cheap drug stocks). Small cap pharmas constitute about 20% of my portfolio, but about 70% of the volatility. I own a lot more of them than I should.
Yeah, it would be ironic ... and highly improbable. The only thing more improbable would be if Shire would buy a company where the CFO and a lot of other key employees are ex-Shire. This would guarantee that the last dollar in SGYP's coffers went to class action law firms.
My post wasn't "snippy". It was accurate, and as usual, contained verifiable facts. Yours was, as usual, wild and inaccurate invention.
It has probably escaped the attention of those circulating this rumor that AGN has a huge stake in IRWD (50% of US rights), which they recently increased by buying the rights for Linzess in Meixico and Constella (European name for Linzess) in Europe, eastern Europe, Turkey, etc.from Almirall.
PS One should note that ibrutinib was the first truly effective drug for CLL.... which is a little more serious than constipation.
These are charming fables which you keep concocting. PCYC didn't " go from under a dollar after a massive drop to selling itself for $150 within a year and a half". Not a single syllable of that is correct. In 2010, PCYC was selling for around 5 a share. By 2010, it worked its way up to 20. As the CLL trials of ibrutinib became increasingly impressive, it continued to climb, and by the beginning of 2014, it had gone up to over 150. At this point it started to weaken, and went down to the 80's. However, by the end of 2014, it had recovered and was again trading at around 140 when JNJ made their offer for the rest of the company (They already owned half) not for 150, but for 260. I remember this vividly because I owned it at around 20 and foolishly sold out my position at around 120. This cost me about $260,000 in additional profit.
The point is, you are misleading people by suggesting that the stock zoomed up from 1 to 150 in a year and a half. The stock, over a period of about 5 years, worked its way up from about 5 to around 150. It was bought out for a premium of less than 100%. The telltale part - which I missed - was when it continued to rebound from the falloff to 80 for no apparent reason.
Yep. How many went for it again? Allergan owns a major slice of IRWD and are not about to invest a large chunk of change to create a competitor.
I gather you're not going to tell me the id that you use when posting on the DVAX board, thereby depriving me of your sage observations.
I thought the consensus here was that the short position had vaporized recently. Since the runup last June/July, this stock has not behaved in a way that would indicate a major retail short position. But nostalgia is persistent, since it was obvious that a sizable retail short position produced that run to 10, you keep trying to wish it into existence. The simple fact is that there have never been shares available for shorting. And thee is no one on this board saying, "Look at all the money I'm making by being short."
This stock is overowned by people who do not realize the dynamics of the market. Ironwood is the most conservative small pharma I own. It'snnot going to be acquired (in reality, it already has been acquired) or double overnight. But I expect it to appreciate gradually over the long term. It is building a dominant position in CIC and IBS-C, and will be very hard to dislodge. The pharma world knows this, which is why they have shown no interest in buying SGYP or partnering with them. The delusion that this stock - or any one stock - will make you rich is dangerous and I am trying to provide a rational dissent to those who would persuade you otherwise.
Not, to my regret, a shortseller of SGYP. The only way a retail investor can short this is by buying puts. I don't trade options, but for a stock which seems to have so many ardent fans, the spreads seem very thin.
PS i last posted on the DVAX board two days ago. Under the same id I have always used. Makes things simpler. I was arguing that they needed a partnership with international drug companies to realize the potential of the vaccine. If you are short DVAX, as you say, these have not been good days for you. But I'll bet you just had a few puts. I am probably a lot older than you. I am not looking for short term gains, butntrying to establish positions in stocks which will produce long term gains, which, in my opinion, is the only way retail investors make real money.